Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leo Luznik

Showing results (1-10 of 161) with videos related to

Pageof 17
Sort By:
Leukemia & Lymphoma|August 5, 2006
Finding the best way to train the immune system against lymphomaLeo Luznik
Bone Marrow Transplantation|November 20, 2020
PTCy and "The Story of the Three Bears"Vedran Radojcic, Leo Luznik
Blood Advances|June 27, 2025
Younger haplo-donors improve older patient survival outcomesAhmad Ghorab, Leo Luznik
Blood|November 11, 2017
Notching up B-cell pathology in chronic GVHDVedran Radojcic, Leo Luznik
Blood|September 14, 2019
PTCY keeps on giving!Vedran Radojcic, Leo Luznik
The Journal of Clinical Investigation|May 8, 2019
Mechanism of action of posttransplantation cyclophosphamide: more than meets the eyeVedran Radojcic, Leo Luznik
Blood|July 24, 2025
Inhibiting JAK1: lowering CRS, CAR stays on trackAkiva Diamond, Leo Luznik
Immunologic Research|January 13, 2010
High-dose, post-transplantation cyclophosphamide to promote graft-host tolerance after allogeneic hematopoietic stem cell transplantationLeo Luznik, Ephraim J Fuchs
Hematology. American Society of Hematology. Education Program|December 7, 2019
How we perform haploidentical stem cell transplantation with posttransplant cyclophosphamideShannon R McCurdy, Leo Luznik
Blood Reviews|May 17, 2023
Relapse after allogeneic transplantation with post-transplant cyclophosphamide: Shattering myths and evolving insightShannon R McCurdy, Leo Luznik
Pageof 17

Showing results (1-10 of 161) with videos related to

Sort By:
Pageof 17
Leukemia & Lymphoma|August 5, 2006
Finding the best way to train the immune system against lymphomaLeo Luznik
Bone Marrow Transplantation|November 20, 2020
PTCy and "The Story of the Three Bears"Vedran Radojcic, Leo Luznik
Blood Advances|June 27, 2025
Younger haplo-donors improve older patient survival outcomesAhmad Ghorab, Leo Luznik
Blood|November 11, 2017
Notching up B-cell pathology in chronic GVHDVedran Radojcic, Leo Luznik
Blood|September 14, 2019
PTCY keeps on giving!Vedran Radojcic, Leo Luznik
The Journal of Clinical Investigation|May 8, 2019
Mechanism of action of posttransplantation cyclophosphamide: more than meets the eyeVedran Radojcic, Leo Luznik
Blood|July 24, 2025
Inhibiting JAK1: lowering CRS, CAR stays on trackAkiva Diamond, Leo Luznik
Immunologic Research|January 13, 2010
High-dose, post-transplantation cyclophosphamide to promote graft-host tolerance after allogeneic hematopoietic stem cell transplantationLeo Luznik, Ephraim J Fuchs
Hematology. American Society of Hematology. Education Program|December 7, 2019
How we perform haploidentical stem cell transplantation with posttransplant cyclophosphamideShannon R McCurdy, Leo Luznik
Blood Reviews|May 17, 2023
Relapse after allogeneic transplantation with post-transplant cyclophosphamide: Shattering myths and evolving insightShannon R McCurdy, Leo Luznik
Pageof 17